BetterLife Pharma Inc. (OTCMKTS:BETRF – Get Free Report) was the target of a significant drop in short interest in October. As of October 15th, there was short interest totalling 100 shares, a drop of 80.0% from the September 30th total of 500 shares. Based on an average trading volume of 25,300 shares, the days-to-cover ratio is currently 0.0 days.
BetterLife Pharma Price Performance
OTCMKTS BETRF remained flat at $0.09 during trading hours on Friday. BetterLife Pharma has a one year low of $0.03 and a one year high of $0.15. The business’s 50 day moving average price is $0.10 and its 200-day moving average price is $0.09. The company has a market capitalization of $11.65 million, a P/E ratio of -3.00 and a beta of 1.23.
BetterLife Pharma (OTCMKTS:BETRF – Get Free Report) last posted its quarterly earnings data on Wednesday, September 25th. The company reported ($0.01) earnings per share (EPS) for the quarter.
About BetterLife Pharma
BetterLife Pharma Inc, a biotechnology company, engages in the development and commercialization of compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections.
Read More
- Five stocks we like better than BetterLife Pharma
- 3 Healthcare Dividend Stocks to Buy
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- What is the Shanghai Stock Exchange Composite Index?
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- Learn Technical Analysis Skills to Master the Stock Market
- MarketBeat Week in Review – 10/21- 10/25
Receive News & Ratings for BetterLife Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BetterLife Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
